PortfoliosLab logoPortfoliosLab logo
MO vs. JNJ
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MO vs. JNJ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Altria Group, Inc. (MO) and Johnson & Johnson (JNJ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MO achieves a 27.30% return, which is significantly higher than JNJ's 13.72% return. Over the past 10 years, MO has underperformed JNJ with an annualized return of 8.10%, while JNJ has yielded a comparatively higher 10.21% annualized return.


MO

1D
2.25%
1M
2.88%
YTD
27.30%
6M
28.89%
1Y
30.10%
3Y*
26.90%
5Y*
16.44%
10Y*
8.10%

JNJ

1D
2.02%
1M
4.22%
YTD
13.72%
6M
16.55%
1Y
55.27%
3Y*
17.11%
5Y*
10.05%
10Y*
10.21%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MO vs. JNJ - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MO
Altria Group, Inc.
27.30%18.17%40.76%-3.70%4.37%24.18%-10.21%7.87%-27.14%9.45%
JNJ
Johnson & Johnson
13.72%47.48%-4.81%-8.58%5.97%11.44%10.82%16.22%-5.13%24.43%

Correlation

The correlation between MO and JNJ is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.31

Correlation (3Y)
Calculated over the trailing 3-year period

0.38

Correlation (5Y)
Calculated over the trailing 5-year period

0.38

Correlation (10Y)
Calculated over the trailing 10-year period

0.35

Correlation (All Time)
Calculated using the full available price history since Jan 5, 1970

0.35

Fundamentals

Market Cap

MO:

$120.77B

JNJ:

$569.17B

EPS

MO:

$4.79

JNJ:

$8.65

PE Ratio

MO:

15.06

JNJ:

26.92

PEG Ratio

MO:

0.32

JNJ:

0.90

PS Ratio

MO:

5.56

JNJ:

5.88

Total Revenue (TTM)

MO:

$21.82B

JNJ:

$96.36B

Gross Profit (TTM)

MO:

$14.80B

JNJ:

$66.60B

EBITDA (TTM)

MO:

$11.70B

JNJ:

$31.62B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MO vs. JNJ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MO
MO Risk / Return Rank: 7474
Overall Rank
MO Sharpe Ratio Rank: 7979
Sharpe Ratio Rank
MO Sortino Ratio Rank: 7272
Sortino Ratio Rank
MO Omega Ratio Rank: 7474
Omega Ratio Rank
MO Calmar Ratio Rank: 7373
Calmar Ratio Rank
MO Martin Ratio Rank: 7474
Martin Ratio Rank

JNJ
JNJ Risk / Return Rank: 9494
Overall Rank
JNJ Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
JNJ Sortino Ratio Rank: 9797
Sortino Ratio Rank
JNJ Omega Ratio Rank: 9595
Omega Ratio Rank
JNJ Calmar Ratio Rank: 9191
Calmar Ratio Rank
JNJ Martin Ratio Rank: 9393
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MO vs. JNJ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Altria Group, Inc. (MO) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MOJNJDifference
Sharpe ratioReturn per unit of total volatility

-1.95

Sortino ratioReturn per unit of downside risk

-2.90

Omega ratioGain probability vs. loss probability

1.26

1.59

-0.33

Calmar ratioReturn relative to maximum drawdown

1.84

5.07

-3.22

Martin ratioReturn relative to average drawdown

4.65

15.08

-10.42

MO vs. JNJ - Sharpe Ratio Comparison

The current MO Sharpe Ratio is 1.35, which is lower than the JNJ Sharpe Ratio of 3.30. The chart below compares the historical Sharpe Ratios of MO and JNJ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


MOJNJDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.35

3.30

-1.95

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.80

0.60

+0.20

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.35

0.55

-0.20

Sharpe Ratio (All Time)

Calculated using the full available price history

0.70

0.54

+0.16

Drawdowns

MO vs. JNJ - Drawdown Comparison

The maximum MO drawdown since its inception was -65.43%, which is greater than JNJ's maximum drawdown of -50.67%. Use the drawdown chart below to compare losses from any high point for MO and JNJ.


Loading charts...

Drawdown Indicators


MOJNJDifference

Max Drawdown

Largest peak-to-trough decline

-65.43%

-50.67%

-14.76%

Max Drawdown (1Y)

Largest decline over 1 year

-16.40%

-10.96%

-5.44%

Max Drawdown (3Y)

Largest decline over 3 years

-16.40%

-15.95%

-0.45%

Max Drawdown (5Y)

Largest decline over 5 years

-25.83%

-18.41%

-7.42%

Max Drawdown (10Y)

Largest decline over 10 years

-53.69%

-27.37%

-26.32%

Current Drawdown

Current decline from peak

-3.17%

-5.81%

+2.64%

Average Drawdown

Average peak-to-trough decline

-11.93%

-11.88%

-0.05%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.48%

3.68%

+2.80%

Volatility

MO vs. JNJ - Volatility Comparison

Altria Group, Inc. (MO) has a higher volatility of 6.78% compared to Johnson & Johnson (JNJ) at 5.90%. This indicates that MO's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MOJNJDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.78%

5.90%

+0.88%

Volatility (6M)

Calculated over the trailing 6-month period

17.26%

12.49%

+4.77%

Volatility (1Y)

Calculated over the trailing 1-year period

22.45%

16.85%

+5.60%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

20.64%

16.87%

+3.77%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

22.95%

18.46%

+4.49%

Dividends

MO vs. JNJ - Dividend Comparison

MO's dividend yield for the trailing twelve months is around 5.82%, more than JNJ's 2.25% yield.


PositionTTM20252024202320222021202020192018201720162015
JNJ
Johnson & Johnson
2.25%2.48%3.40%3.00%2.52%2.45%2.53%2.57%2.74%2.38%2.73%2.87%
MO
Altria Group, Inc.
5.82%7.21%7.65%9.52%8.05%7.43%8.29%6.57%6.07%3.56%3.48%3.73%

Financials

MO vs. JNJ - Financials Comparison

This section allows you to compare key financial metrics between Altria Group, Inc. and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


5.00B10.00B15.00B20.00B25.00B20222023202420252026
5.43B
24.06B
(MO) Total Revenue
(JNJ) Total Revenue
Values in USD except per share items

MO vs. JNJ - Profitability Comparison

The chart below illustrates the profitability comparison between Altria Group, Inc. and Johnson & Johnson over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

62.0%64.0%66.0%68.0%70.0%72.0%20222023202420252026
64.6%
71.5%
Portfolio components
MO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Altria Group, Inc. reported a gross profit of 3.51B and revenue of 5.43B. Therefore, the gross margin over that period was 64.6%.

JNJ - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a gross profit of 17.20B and revenue of 24.06B. Therefore, the gross margin over that period was 71.5%.

MO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Altria Group, Inc. reported an operating income of 2.96B and revenue of 5.43B, resulting in an operating margin of 54.5%.

JNJ - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported an operating income of 6.40B and revenue of 24.06B, resulting in an operating margin of 26.6%.

MO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Altria Group, Inc. reported a net income of 2.18B and revenue of 5.43B, resulting in a net margin of 40.2%.

JNJ - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a net income of 5.24B and revenue of 24.06B, resulting in a net margin of 21.8%.


Frequently Asked Questions


MO and JNJ have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MO has higher volatility (6.78%) compared to JNJ (5.90%). In terms of maximum drawdown, MO dropped -65.43% vs JNJ's -50.67%.

JNJ currently has the higher Sharpe Ratio (3.30 vs 1.35), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MO and JNJ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer